Skip to main content
. Author manuscript; available in PMC: 2019 Jan 25.
Published in final edited form as: Vaccine. 2017 Dec 14;36(4):438–441. doi: 10.1016/j.vaccine.2017.12.017

Fig. 2.

Fig. 2

Expression of effector function of HSV-2 gB-specific T cells in mice following primary immunization with gB-NF vaccine given with CpG or Gardiquimod adjuvants. A. HSV-2 gB-specific cytolytic activity detected by in vivo CTL assay. Results shown are pooled from two experiments of identical design. * P < .05, one way ANOVA. B. Expression of cytokines following peptide stimulation of lymphocytes following primary immunization detected by intracellular cytokine staining. Results shown are pooled from two experiments of identical design.